ANALYSE THE EFFECT OF VISHATINDUKA TAILAM ON SCIATICA (BACK PAIN)

PHARMACEUTICAL STANDARDISATION OF VISHATINDUKA TAILAM AND ITS EFFECT ON GRIDHRASI

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035349

Enrollment

Registered

2021-08-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: vishatinduka tailam: Effect of vishatinduka tailam in sciatica (back ache). Dose - Quantity sufficient Route of administration - External application Control Intervention1: NOT APPLICAB

Eligibility

Inclusion criteria

Inclusion criteria: Patient irrespective of Gender and Occupation will be selected. Patient age between 18-60 years. Patient willing for study and follow up.

Exclusion criteria

Exclusion criteria: Patient suffering from Structural deformity like lordosis, kyphosis and scoliosis (After doing physical examination of back including inspection, palpation, gait). Patient under pediatric age group and those who are above 60 years. Patient suffering from any systemic disease like diabetic mellitus, hypertension, thyroid dysfunction or the patient under any concomitant medications. Any neoplasms like osteoma and myeloma.

Design outcomes

Primary

Measure	Time frame
SLR Test â?? Active and Passive Schobers Test Assessment will be done based on Oswestry low back pain disability questionnaire.Timepoint: 1 WEEK	—

Secondary

Measure	Time frame
analyse effect of vishatinduka tailam in sciaticaTimepoint: 2 WEEKS	—

Countries

India

Contacts

Public ContactDr V Vanitha

Sri jayendra saraswathi ayurveda college and hospital

virupakshgupta@gmail.com8555805497

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026